French company offers "first medicine" to treat coronavirus patients

   

The French pharmaceutical group Sanofi is offering "Plaquenil" antimalarial drugs to treat 300,000 people with the coronavirus, AFP reported On Wednesday.

The Sanofi group announced that "Plaquenil", the antimalarial drug it produces, has demonstrated "promising" results in the treatment of patients with the novel coronavirus and is therefore ready to provide millions of doses to the French authorities.

"In light of the encouraging results of a study on this drug, Sanofi pledges to put its medicine within France's reach and provide millions of doses, a quantity that could allow the treatment of 300,000 patients," a spokesman for the group told AFP. To cooperate with the French authorities "to confirm these results".

On Tuesday, more than 7,900 people worldwide died of Covid-19, while the number of infections approached nearly 200,000.

Also on Tuesday, China approved clinical trials of the first "vaccine" developed to fight the novel coronavirus, less than 24 hours after similar trials in the United States.

According to a report in the People's Daily, China has authorized clinical trials of its first vaccine to fight the coronavirus.

The team of researchers working on the experiments, led by Dr. Qin Wei of the Academy of Military Medical Sciences in China, is led by the team of researchers working on the experiments, the report said.